Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IBRX | APLS | MLTX | ||
| Company | Immunitybio Inc | Apellis Pharmaceuticals Inc | Moonlake Immunotherapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.91 | 27.00 | 50.07 | ||
| High | 5.15 | 28.14 | 52.09 | ||
| Low | 4.84 | 26.62 | 48.91 | ||
| Last | 5.03 | 27.75 | 51.86 | ||
| Change | +0.16 | +0.26 | +2.04 | ||
| % Change | +3.28% | +0.95% | +4.09% | ||
| Volume | 3,366,800 | 1,535,900 | 252,000 | ||
| 20-Day Average Volume | 10,274,205 | 4,094,000 | 243,240 | ||
| Previous Close | 4.88 | 27.49 | 49.82 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.25 | 28.02 | 49.44 | ||
| 20-Day Raw Stochastic | 19.84% | 52.79% | 69.17% | ||
| 20-Day Relative Strength | 53.89% | 45.55% | 54.97% | ||
| Weighted Alpha | -33.60 | -51.21 | +13.59 | ||
| Today's Opinion | 24% Sell | 100% Sell | 88% Buy | ||
| Previous Opinion | 24% Sell | 100% Sell | 72% Buy | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.39% since 11/14/24 | -1.10% since 11/14/24 | -1.22% since 11/14/24 | ||
| Low | 4.43 on 11/15/24 | 25.76 on 11/18/24 | 47.33 on 11/18/24 | ||
| High | 5.38 on 11/19/24 | 30.80 on 11/19/24 | 52.24 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | +41.83% since 10/21/24 | +3.24% since 10/21/24 | +5.79% since 10/21/24 | ||
| Low | 3.37 on 10/23/24 | 24.34 on 11/05/24 | 45.24 on 10/31/24 | ||
| High | 7.48 on 10/25/24 | 30.80 on 11/19/24 | 54.81 on 11/12/24 | ||
| 3-Month | |||||
| %Chg | +14.43% since 08/21/24 | -30.37% since 08/21/24 | +5.13% since 08/21/24 | ||
| Low | 3.19 on 10/11/24 | 24.34 on 11/05/24 | 44.71 on 09/06/24 | ||
| High | 7.48 on 10/25/24 | 41.94 on 09/09/24 | 56.00 on 10/07/24 | ||
| 6-Month | |||||
| %Chg | -26.01% since 05/21/24 | -34.80% since 05/21/24 | +32.87% since 05/21/24 | ||
| Low | 3.19 on 10/11/24 | 24.34 on 11/05/24 | 37.55 on 06/24/24 | ||
| High | 7.63 on 06/24/24 | 43.99 on 05/22/24 | 56.00 on 10/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,397,051 | 3,419,563 | 3,183,747 | ||
| Shares Outstanding, K | 696,831 | 124,393 | 63,905 | ||
| Annual Sales | 620,000 | 396,590,000 | 0 | ||
| Annual Net Income | -583,200,000 | -528,630,000 | -36,010,000 | ||
| Last Quarter Sales | 6,110,000 | 196,830,000 | 0 | ||
| Last Quarter Net Income | -85,730,000 | -57,450,000 | -35,390,000 | ||
| 60-Month Beta | 0.99 | 0.87 | 1.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.14 on 11/12/24 | -0.46 on 11/05/24 | -0.56 on 11/07/24 | ||
| Latest Earnings Date | 11/13/24 | 11/05/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||